FRS102 1A Filleted



Mills Pharmacies Limited

Chartered Accountants' Report to the Board of Directors for the preparation of the unaudited financial statements

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Mills Pharmacies Limited for the year ended 31 August 2025 which comprise the Profit and loss account, Balance sheet and the notes to the financial statements from the company's accounting records and from information and explanations you have given us.

As a member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at https://www.icaew.com/regulation.

This report is made solely to the Board of Directors of Mills Pharmacies Limited, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the financial statements of Mills Pharmacies Limited and state those matters that we have agreed to state to them, as a body, in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Mills Pharmacies Limited and its Board of Directors, as a body, for our work, or for this report.

It is your duty to ensure that Mills Pharmacies Limited has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of Mills Pharmacies Limited. You consider that Mills Pharmacies Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the accounts of Mills Pharmacies Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.

Osbourne Sandy & Co
10 Grange Terrace
Sunderland
SR2 7DF
United Kingdom

	Date:	28 May 2026

1


Company registration number:						04045959
Mills Pharmacies Limited

Balance sheet
as at 31 August 2025

		2025		2024
	Note	£	£	£	£
Fixed assets
Tangible assets	4	766,109		782,784
Investments	5	364,879		414,131
			1,130,988		1,196,915
Current assets
Debtors		339,676		335,130
Cash at bank and in hand		16,972		7,653
			356,648		342,783
Creditors: amounts falling due within one year			(18,968)		(28,215)
Net current assets			337,680		314,568
Total assets less current liabilities			1,468,668		1,511,483
Creditors: Amounts falling due after more than one year			(31,551)		(43,640)
NET ASSETS			1,437,117		1,467,843

Capital and reserves
Called up share capital			100		100
Other reserves			552,400		552,400
Profit and loss account			884,617		915,343
TOTAL EQUITY			1,437,117		1,467,843


The company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies for the year ended 31 August 2025.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities to comply with the Companies Act 2006 in respect to accounting records and the preparation of financial statements.

2


	Company registration number:		04045959
	Mills Pharmacies Limited

	Balance sheet - continued
	as at 31 August 2025

	The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

	In accordance with Section 444 of the Companies Act 2006, the Profit and loss account has not been delivered to the Registrar.

	These financial statements were approved by the Board of directors and authorised for issue on 28 May 2026 and signed on its behalf by:

	Mr N Herdman, Director
	28 May 2026

	3


Mills Pharmacies Limited

Notes to the financial statements
for the year ended 31 August 2025


1	Company information

	Mills Pharmacies Limited is a private company registered in England and Wales. Its registered number is 04045959. The company is limited by shares. Its registered office is 10 Grange Terrace, Sunderland, Tyne and Wear, SR2 7DF.

2	Accounting policies

	Basis of preparing the financial statements
	These financial statements have been prepared in accordance with Financial Reporting Standard 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” including the provisions of Section 1A “Small Entities” and the Companies Act 2006. The financial statements have been prepared under the historic cost convention.

	Going concern
	In preparing these financial statements, the directors have assessed whether there are any material uncertainties related to events or conditions that cast significant doubt upon the company's ability to continue as a going concern. In making this assessment, the directors take into account all available information about the future which is at least 12 months from the date that the financial statements are authorised for issue.

	The directors consider that the company has adequate resources to continue in business for the foreseeable future and that it is appropriate to adopt the going concern basis in preparing the financial statements.

	Tangible fixed assets
	Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.

	Land and buildings:
	Investments and Property	-	0% reducing balance
	Plant and machinery etc.:
	Plant and machinery	-	12.5% straight line
	Motor vehicles	-	20% straight line

	Taxation
	Taxation for the year comprises current taxation. Tax is recognised in the Profit and loss account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

	Current taxation assets and liabilities are not discounted.

	Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

4


Mills Pharmacies Limited

Notes to the financial statements - continued
for the year ended 31 August 2025

2	Accounting policies - continued

	Hire purchase and leasing commitments
	Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

	The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

3	Average number of employees

	During the year the average number of employees was 6 (2024 - 6).

4	Tangible fixed assets

		Land and buildings	Plant and machinery etc.	Totals
		£	£	£
	Cost
	At 1 September 2024	708,856	220,503	929,359
	Disposals	-	(30,390)	(30,390)
	At 31 August 2025	708,856	190,113	898,969

	Depreciation
	At 1 September 2024	-	146,575	146,575
	Charge for year	-	16,675	16,675
	Eliminated on disposal	-	(30,390)	(30,390)
	At 31 August 2025	-	132,860	132,860

	Net book value
	At 31 August 2025	708,856	57,253	766,109

	At 31 August 2024	708,856	73,928	782,784


5


	Company registration number:	04045959

	Annual report and unaudited financial statements
	for the year ended 31 August 2025
	for
	Mills Pharmacies Limited


	Pages for filing with the Registrar